Humira Side Effects: What to Expect in 2026

If your rheumatologist just handed you a Humira prescription, odds are your first two questions were "how bad are the side effects?" and "how am I going to afford this?" Both are fair. Adalimumab — the generic name for Humira — has been one of the best-selling biologics on Earth for more than two decades, and for good reason. It also carries two FDA boxed warnings, a list of serious side effects that can sound alarming on the first read, and a sticker price that still runs past $7,000 for a month's supply of the brand-name injection.

Most people tolerate Humira well. Most people also overpay for it. Here's an honest look at what side effects are common, which ones actually matter, and how the biosimilar market has quietly reshaped what this medication costs in 2026.

What Humira does and why the side effects happen

Humira is a tumor necrosis factor (TNF) blocker, delivered as a subcutaneous injection every other week for most conditions. It's FDA-approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. TNF is a messenger your immune system uses to drive inflammation. Blocking it calms inflammatory disease — but it also dials down part of your ability to fight infection. That tradeoff explains almost every serious side effect on Humira's label.

Understanding the mechanism helps the side-effect list make sense. It's not a random collection of risks. It's the predictable downstream of quieting an over-active immune system.

The most common Humira side effects

In clinical trials, the side effects reported most often were:

• Injection site reactions — redness, itching, pain, swelling, or bruising where the needle goes in. Usually mild. Most resolve in a few days.
• Upper respiratory infections — cold-like symptoms, sinusitis, sore throat
• Headache
• Rash — often mild and localized; rarely a sign of something more serious
• Nausea

Injection site reactions alone show up in roughly 1 in 5 to 1 in 4 users in most studies. They're the side effect you're most likely to encounter, and also the one most easily managed with simple technique changes (more on that below).

Side effects after your first dose of Humira

A question that comes up constantly: is the first shot worse than later ones? Not usually. The risk profile stays fairly consistent throughout treatment, with one exception — allergic reactions are slightly more likely with early doses. That's why your first injection is often supervised in a clinic setting.

Some people feel flu-like symptoms (fatigue, mild aches, low-grade fever) in the 24 to 48 hours after an injection, especially early on. These generally fade as your body adjusts.

Do Humira side effects go away?

Mild side effects usually fade within days to a few weeks as your system adjusts. Injection site reactions tend to become less intense with each dose. If a side effect persists beyond a month or gets worse, that's a reason to call your doctor rather than push through.

Serious side effects that deserve your attention

Rare doesn't mean impossible. These are the ones worth knowing how to recognize:

These are all reasons the FDA and your prescriber take pre-treatment screening seriously. Expect a TB test, hepatitis B screening, a review of your vaccination history, and usually baseline liver enzymes before your first dose.

Humira's two boxed warnings

A boxed warning is the strongest safety alert the FDA can put on a drug. Humira carries two.

Serious infections. Because TNF blockers reduce your immune response, infections that would otherwise be minor can become dangerous. Tuberculosis reactivation is the classic concern — which is why you'll be tested for latent TB before starting. Invasive fungal infections (histoplasmosis, coccidioidomycosis, aspergillosis) are also on the label. If you develop a fever that doesn't explain itself, don't wait it out.

Risk of cancer. Children and adolescents treated with TNF blockers have had lymphomas and other cancers, including a rare and aggressive type called hepatosplenic T-cell lymphoma. In adults, there's an increased risk of skin cancers (mostly non-melanoma) and, less commonly, lymphomas. The absolute risk is still low, but it's why dermatology checks and symptom awareness matter.

Humira long-term side effects

With a medication you may take for years or decades, the long tail matters as much as the first month. Issues that can develop or persist with long-term Humira use include:

• Increased cancer risk, particularly skin cancers — annual dermatology screening is standard advice
• Chronic worsening of existing heart failure
• Ongoing susceptibility to serious infections
• Rarely, new-onset demyelinating disease or worsening of existing multiple sclerosis
• Development of antibodies against Humira (anti-drug antibodies) that reduce its effectiveness over time

If Humira stops working the way it did at the start, your doctor can check drug and antibody levels. It's not necessarily a permanent failure — sometimes a dose adjustment or a switch to a different TNF blocker brings results back.

The injection site burn problem — and the fix

Ask any patient forum and you'll hear the same complaint: the injection stings. For some, it's mild. For others, it's a searing burn that lasts 10 to 15 seconds and makes every other week miserable.

The original Humira formulation contained citrate buffer, which is the main reason for the burn. In 2018, AbbVie reformulated the brand-name product to a citrate-free, higher-concentration version that most people find significantly more comfortable. All of the FDA-approved adalimumab biosimilars that have launched since then ship citrate-free formulations too.

Other practical ways to minimize injection site reactions:

• Let the pen sit at room temperature for 15 to 30 minutes before injecting (cold medication stings more)
• Rotate between your thigh and abdomen — never inject into the same spot twice in a row
• Pinch the skin gently; don't press the pen in hard
• Avoid areas that are bruised, hard, or irritated
• Apply a cold pack afterward if redness persists

What Humira costs in 2026 — and the biosimilar reality

This is where the conversation has changed the most. From 2002 until mid-2023, Humira held a near-monopoly in the US, and list prices climbed above $7,000 per month. Since the patent cliff in 2023, the FDA has approved multiple adalimumab biosimilars. By 2026, the biosimilars available in the US include Amjevita, Cyltezo, Hyrimoz, Hadlima, Yuflyma, Yusimry, Idacio, Abrilada, Hulio, and Simlandi — all referencing the same molecule, all FDA-approved as biosimilar or (in some cases) interchangeable.

What that means in practice:

• List prices for biosimilars usually land 55% to 85% below brand-name Humira's list
• Insurance coverage is uneven — some plans still prefer brand Humira because of rebate structures; others have moved biosimilars to preferred tier
• Cash-pay prices through legitimate channels can drop the monthly cost of a 40 mg dose substantially compared with the US brand sticker
• Yusimry has made particular waves for offering transparent cash pricing through direct-to-consumer channels

For cash-pay patients, the equation is straightforward: the same active ingredient, the same safety profile, and often a fraction of the cost. Biosimilars go through rigorous FDA review to prove they match the reference product in structure, potency, and clinical effect. They're not a knockoff — they're the regulated equivalent.

When side effects aren't the only reason to reconsider

Sometimes the reason to talk to your doctor about Humira isn't a physical symptom — it's that you're rationing doses because you can't afford them. Skipping doses is its own clinical risk. Under-dosing TNF blockers is associated with loss of response, development of anti-drug antibodies, and flare-ups of the underlying disease.

If you're stretching doses because of cost, that's a conversation worth having with your prescriber. Switching to a less expensive biosimilar, or sourcing through a cash-pay network, keeps you on schedule without the same financial hit. The medical plan and the financial plan need to match.

Humira side effects FAQ

What are the worst side effects of Humira?

The side effects with the highest potential for harm are the ones covered by the FDA's boxed warnings: serious infections (including TB and invasive fungal infections) and cancer (particularly lymphomas in younger patients and skin cancers in adults). Heart failure, liver damage, nervous system problems, and severe allergic reactions are also on the serious list. These are uncommon, but every Humira user should know the warning signs.

Are there neurological side effects of Humira?

Rarely, yes. TNF blockers including adalimumab can trigger or worsen demyelinating disorders like multiple sclerosis, optic neuritis, and Guillain-Barré syndrome. Early symptoms can include numbness, tingling, vision changes, or weakness in the arms or legs. Anyone with a personal or family history of MS or a similar condition should tell their prescriber before starting.

Does Humira cause weight gain?

Clinical trials didn't list weight gain as a common Humira side effect. That said, sudden weight gain in someone on Humira deserves a conversation with a doctor because it can signal heart failure (a rare but serious side effect). Some patients do gain weight on Humira, but most of the time it's tied to the underlying condition improving — better disease control often means better appetite and less inflammatory catabolism.

How high is the Humira cancer risk?

The absolute risk remains low, but higher than background. In children and adolescents, the lymphoma risk is well documented — including the rare hepatosplenic T-cell lymphoma almost exclusively reported in young men treated for inflammatory bowel disease. In adults, the most consistent signal is an increased risk of non-melanoma skin cancer. Annual skin checks and staying aware of any new or changing lumps, sores, or moles are the standard responses.

Can you drink alcohol on Humira?

There's no direct interaction between alcohol and adalimumab. Heavy drinking, though, stresses the liver and can increase the already-present risk of liver enzyme elevation in Humira users. And for conditions like Crohn's disease and psoriasis, alcohol can worsen the underlying disease. Moderation — or abstaining if your disease is active — is the practical answer.

How do I know if my side effects are serious?

A useful rule of thumb: if the symptom is at the injection site, mild, and fading, it's probably nothing. If the symptom is systemic (fever, unexplained weight loss, shortness of breath, jaundice, neurological changes, persistent abdominal pain), don't wait — call your doctor. Severe allergic reactions (throat swelling, difficulty breathing, widespread hives) are a 911 call.

The bottom line

Most people on Humira do well on it. The common side effects — injection reactions, mild infections, headache — usually settle within the first few months. The serious risks are real, but rare enough that routine monitoring and pre-treatment screening catch most problems before they become crises. The more common frustrations are the burn at the injection site and the cost.

Both of those are solvable in 2026 in ways they weren't a few years ago. Citrate-free formulations have largely fixed the sting. Biosimilar competition has broken the pricing monopoly. If you're on brand-name Humira, paying retail, and feeling a burn every other week, there's a good chance you're paying more and suffering more than you need to. Talk to your prescriber. Check cash-pay prices. The medication that keeps your disease under control shouldn't be the reason you skip doses.

---

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.